The ITN is currently seeking proposals for clinical tolerance trials in solid organ transplantation. We are interested in trials using cell therapy to acheive tolerance in solid organ (liver and kidney) transplant. The ideal proposal should have a testable mechanism of tolerance induction and a strategy for assays to investigate this mechanism.
Full details are included in the RFP. Proposals should be submitted to Philip Bernstein, Executive Director of Strategic Review and Planning (pbernstein@immunetolerance.org), by January 29th, 2016.